Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.109786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Hanan Fawzy Mohamed Abdallah und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdallah, H. F. M., Elshenshawy, H. M. A., Khedr, R. A. E. M., Alshahat, M. A. M., & Halim, A. A. F. (2026). Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.109786
Vancouver
Abdallah HFM, Elshenshawy HMA, Khedr RAEM, Alshahat MAM, Halim AAF. Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.109786
BibTeX
@article{Abdallah2026,
author = {Abdallah, Hanan Fawzy Mohamed and Elshenshawy, Hala Mohamed Ahmed and Khedr, Rasha Abd El-Ghany Mohamed and Alshahat, Maiy Abdul-Raheim Mohammad and Halim, Amal Ahmed Fouad},
title = {Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.109786}
}
EUVIMED